Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ballal Rahul D.
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Smith Cynthia
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Goff Brian
Agios Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Agios Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Agios Pharmaceuticals | 8-K: Agios Reports Business Highlights and Second Quarter 2024 Financial Results
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gheuens Sarah
Agios Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director FOUSE JACQUALYN A
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Smith Cynthia
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CAPELLO JEFFREY D
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ballal Rahul D.
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scadden David
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schenkein David P
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Owen Catherine E.
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ho Maykin
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Foster-Cheek Kaye I
Agios Pharmaceuticals | UPLOAD: Others
Agios Pharmaceuticals | 8-K: Current report
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Foster-Cheek Kaye I
No Data
No Data